• 1
    Butterworth RF, Giguere J-F, Michaud J, Lavoie J, Layrargues GP. Ammonia: key factor in the pathogenesis of hepatic encephalopathy. Neuro-chem Pathol 1987; 6: 112.
  • 2
    Schafer DF, Jones EA. Hepatic encephalopathy and the γ-aminobutyric acid neurotransmitter system. Lancet 1982; i: 1820.
  • 3
    Basile AS, Jones EA, Skolnick P. The pathogenesis and treatment of hepatic encephalopathy: evidence for the involvement of benzodiazepine receptor ligands. Pharmacol Rev 1991; 43: 2771.
  • 4
    Jones EA, Yurdaydin C, Basile AS. The GABA hypothesis–state of the art. Adv Exp Biol Med 1994; 368: 89101.
  • 5
    Torda C. Ammonium ion content and electrical activity of the brain during the preconvulsive and convulsive phases induced by various convulsants. J Pharmacol Exp Therap 1953; 107: 197203.
  • 6
    Iles JF, Jack JJB. Ammonia: assessment of its action on postsynaptic inhibition as a cause of convulsions. Brain 1983; 103: 555578.
  • 7
    Conn HO. Hepatic encephalopathy. In: SchiffL, SchiffER, eds. Diseases of the Liver. Philadelphia: Lippincott, 1993: 10361061.
  • 8
    Lockwood AH, McDonald JM, Reiman RE, Gelbard AS, Laughlin JS, Duffy TE, Plum F. The dynamics of ammonia metabolism in man: effects of liver disease and hyperammonemia. J Clin Invest 1979; 63: 449460.
  • 9
    Stahl J. Studies of the blood ammonia in liver disease. Ann Intern Med 1963; 58: 124.
  • 10
    Raabe WA. Neurophysiology of ammonia intoxication. In: ButterworthRF, Pomier-LayrarguesG, eds. Hepatic Encephalopathy. Pathophysiology and Treatment. Clifton, NJ: Humana, 1988: 4977.
  • 11
    Pappas SC, Ferenci P, Schafer DF, Jones EA. Visual evoked potentials in a rabbit model of hepatic encephalopathy. II. Comparison of hyperammonemic encephalopathy, postictal coma, and coma induced by synergistic neurotoxins. Gastroenterology 1984; 86: 546551.
  • 12
    Flannery DB, Hsia YE, Wolf B. Current status of hyperammonemia syndromes. Hepatology 1982; 2: 495506.
  • 13
    Schafer DF, Jones EA. Hepatic encephalopathy and the gamma-aminobutyric acid neurotransmitter system. Lancet 1982; i: 1820.
  • 14
    Cohn R, Castell DO. The effect of acute hyperammonemia on the electroencephalogram. J Lab Clin Med 1966; 68: 195205.
  • 15
    Jones DB, Mullen KD, Roessle M, Maynard T, Jones EA. Hepatic encephalopathy: application of visual evoked responses to test hypotheses of its pathogenesis in rats. J Hepatol 1987; 4: 118126.
  • 16
    Cooper AJ, Plum F. Biochemistry and physiology of brain ammonia. Physiol Rev 1987; 67: 440519.
  • 17
    Kanamori K, Ross BD, Chung JC, Kuo EL. Severity of hyperammonemic encephalopathy correlates with brain ammonia level and saturation of glutamine synthetase in vivo. J Neurochem 1996; 67: 15841594.
  • 18
    Bassett ML, Mullen K, Skolnick P, Jones EA. Amelioration of hepatic encephalopathy by pharmacologic antagonism of the GAB AA -benzodiazepine receptor complex in a rabbit model of fulminant hepatic failure. Gastroenterology 1987; 93: 10691077.
  • 19
    Schafer DF, Pappas SC, Brody LE, Jacobs R, Jones EA. Visual evoked potentials in a rabbit model of hepatic encephalopathy. I. Sequential changes and comparisons with drug-induced comas. Gastroenterology 1984; 86: 540545.
  • 20
    Ferreira MR, Gammal SH, Jones EA. Resistance to 3-mercaptoproprionic acid-induced seizures in hepatic encephalopathy. Hepatogastroenterology 1997; in press.
  • 21
    Basile AS, Gammal S, Mullen K, Jones EA, Skolnick P. Differential responsiveness of cerebellar Purkinje neurons to GABA and benzodiazepine receptor ligands in an animal model of hepatic encephalopathy. J Neurosci 1988; 8: 24142421.
  • 22
    Gammal S, Basile AS, Geller D, Skolnick P, Jones EA. Reversal of the behavioral and electrophysiological abnormalities of an animal model of hepatic encephalopathy by benzodiazepine receptor ligands. Hepatology 1990; 11: 371378.
  • 23
    Mullen KD, Jones EA. Natural benzodiazepines and hepatic encephalopathy. Semin Liver Dis 1996; 16: 255264.
  • 24
    Basile AS, Hughes R, Harrison P, Murata R, Pannel L, Jones EA, Williams R. Elevated brain concentrations of 1,4-benzodiazepines in fulminant hepatic failure. N Engl J Med 1991; 325: 473478.
  • 25
    Scollo-Lavizzari G, Steinmann E. Reversal of hepatic coma by benzodiazepine antagonist (Ro 15–1788). Lancet 1985; i: 1324.
  • 26
    Bansky G, Meier PJ, Ziegler WH, Walser H, Schmid M, Huber M. Reversal of hepatic coma by benzodiazepine antagonist (Ro 15–1788). Lancet 1985; i: 13241325.
  • 27
    Ferenci P, Herneth A, Steindl P. Newer approaches to therapy of hepatic encephalopathy. Semin Liver Dis 1996; 16: 329338.
  • 28
    Mullen KD, Szauter KM, Kaminsky-Russ K. “Endogenous” benzodiazepine activity in physiological fluids of patients with hepatic encephalopathy. Lancet 1990; 336: 8183.
  • 29
    Majewska MD, Harrison NL, Schwartz RD, Barker JL, Paul SM. Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor. Science 1986; 232: 10041007.
  • 30
    Lambert JJ, Belelli D, Hill-Venning C, Peters JA. Neurosteroids and GA-BAA receptor function. Trends Pharmacol Sci 1995; 16: 295303.
  • 31
    Akwa Y, Sananes N, Gouezou M, Robel P, Baulieu EE, Le Goascogne C. Astrocytes and neurosteroids: metabolism of pregnenolone and dehydroe-piandrosterone. Regulation by cell density. J Cell Biol 1993; 12: 135143.
  • 32
    Itzhak Y, Roig-Cantisano A, Dombro RS, Norenberg MD. Acute liver failure and hyperammonemia increase peripheral-type benzodiazepine receptor binding and pregnenolone synthesis in mouse brain. Brain Res 1995; 705: 345348.
  • 33
    Itzhak Y, Norenberg MD. Ammonia-induced upregulation of peripheral-type benzodiazepine receptors in cultured astrocytes labeled with [3H]PK 11195. Neurosci Lett 1994; 177: 3538.
  • 34
    Basile AS, Skolnick P. Subcellular localization of “peripheral-type” binding sites for benzodiazepines in rat brain. J Neurochem 1986; 46: 305308.
  • 35
    Majewska MD, Schwartz RD. Pregnenolone-sulfate: an endogenous antagonist of the y-aminobutyric acid receptor complex in brain? Brain Res 1987; 404: 355360.
  • 36
    Itzhak Y, Norenberg MD. Attenuation of ammonia toxicity in mice by PK 11195 and pregnenolone sulfate. Neurosci Lett 1994; 182: 251254.
  • 37
    Oja SS, Saransaari P, Wysmyk U, Albrecht J. Loss of GABAB binding sites in the cerebral cortex of rats with acute hepatic encephalopathy. Brain Res 1993; 629: 355357.
  • 38
    Bassett ML, Mullen KD, Scholz B, Fenstermacher JD, Jones EA. Increased brain uptake of y-aminobutyric acid in a rabbit model of hepatic encephalopathy. Gastroenterology 1990; 98: 747757.
  • 39
    Takahashi K, Kameda H, Kataoka M, Sanjou K, Harata N, Akaike N. Ammonia potentiates GABAA response in dissociated rat cortical neurons. Neurosci Lett 1993; 151: 5154.
  • 40
    Ha J-H, Basile AS. Modulation of ligand binding to components of the GABAA receptor complex by ammonia: implications for the pathogenesis of hyperammonemic syndromes. Brain Res 1996; 720: 3544.
  • 41
    Schafer K, Ukida M, Steffen C, Bode C, Zelder O, Bode JC. Effect of ammonia on plasma and cerebrospinal fluid amino acids in dogs with and without portacaval anastomoses. Res Exp Med 1985; 185: 3544.
  • 42
    Rossle M, Luft M, Herz R, Klein B, Lehmann M, Gerok W. Amino acid, ammonia and neurotransmitter concentrations in hepatic encephalopathy: serial analysis in plasma and cerebrospinal fluid during treatment with an adapted amino acid solution. Klin Wochenschr 1984; 62: 867875.
  • 43
    Willow M, Johnston GAR. Dual action of pentobarbitone on GABA binding: role of binding site integrity. J Neurochem 1981; 37: 12911294. 626: